Imipenem cilastatin how supplied: Difference between revisions
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{imipenem cilastatin}} | {{imipenem cilastatin}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{SS}} | ||
==How Supplied== | ==How Supplied== | ||
PRIMAXIN I.V. is supplied as a sterile powder mixture in single dose containers including vials and ADD-Vantage® vials containing imipenem (anhydrous equivalent) and cilastatin sodium as follows: | PRIMAXIN I.V. is supplied as a sterile powder mixture in single dose containers including vials and ADD-Vantage® vials containing imipenem (anhydrous equivalent) and cilastatin sodium as follows: | ||
Latest revision as of 22:36, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
How Supplied
PRIMAXIN I.V. is supplied as a sterile powder mixture in single dose containers including vials and ADD-Vantage® vials containing imipenem (anhydrous equivalent) and cilastatin sodium as follows:
No. 3514 — 250 mg imipenem equivalent and 250 mg cilastatin equivalent and 10 mg sodium bicarbonate as a buffer
NDC 0006-3514-58 in trays of 25 vials.
No. 3516 — 500 mg imipenem equivalent and 500 mg cilastatin equivalent and 20 mg sodium bicarbonate as a buffer
NDC 0006-3516-59 in trays of 25 vials.
No. 3551 — 250 mg imipenem equivalent and 250 mg cilastatin equivalent and 10 mg sodium bicarbonate as a buffer
NDC 0006-3551-58 in trays of 25 ADD‑Vantage® vials.
No. 3552 — 500 mg imipenem equivalent and 500 mg cilastatin equivalent and 20 mg sodium bicarbonate as a buffer
NDC 0006-3552-59 in trays of 25 ADD‑Vantage® vials.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.